NTGRHIGH SIGNALFINANCIAL10-K

NTGR experienced a dramatic collapse in operating cash flow while maintaining growth in gross profit, creating a significant cash generation concern.

The company's operating cash flow fell to just $1.6M from $164.8M in the prior year, representing a near-total evaporation of cash generation capability despite gross profit growing meaningfully. This divergence between profitability and cash flow suggests potential working capital issues, timing of collections, or other operational challenges that could impact the company's financial flexibility and ability to fund operations and growth initiatives.

Comparing 2026-02-13 vs 2025-02-14View on EDGAR →
FINANCIAL ANALYSIS

NTGR presents a mixed financial picture with concerning cash flow dynamics. While gross profit grew notably to $266.2M, the company's operating cash flow collapsed to minimal levels, forcing management to reduce cash reserves by over $76M to $209.9M. Despite this cash pressure, the company increased share buybacks to $50.7M, suggesting management confidence but raising questions about capital allocation priorities given the severe cash flow deterioration.

FINANCIAL STATEMENT CHANGES
Operating Cash Flow
Cash Flow
-99%
$164.8M→$1.6M

Operating cash flow fell 99% — earnings quality concerns; investigate working capital changes and non-cash items.

Share Buybacks
Cash Flow
+53.1%
$33.1M→$50.7M

Share repurchases increased 53.1% — management returning capital, signals confidence in intrinsic value.

Gross Profit
P&L
+35.9%
$195.9M→$266.2M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Cash & Equivalents
Balance Sheet
-26.7%
$286.4M→$209.9M

Cash decreased 26.7% — monitor burn rate and upcoming capital needs.

Current Assets
Balance Sheet
-11.2%
$758.0M→$673.3M

Current assets declined 11.2% — monitor working capital adequacy and short-term liquidity.

LANGUAGE CHANGES
NEW — 2026-02-13
PRIOR — 2025-02-14
ADDED
Such aggregate market value was computed by reference to the closing price of the common stock as reported on the Nasdaq Global Select Market on June 27, 2025.
The number of outstanding shares of the registrant s common stock, $0.001 par value, was 28,113,151 shares as of February 6, 2026.
Risks Related to our Business, Industry and Operations We obtain several key components from limited or sole sources and if these sources fail to satisfy our supply requirements or we are unable to properly manage our supply requirements with our third-party manufacturers, we may lose sales and experience increased component costs.
Optimizing our channel partners' inventory levels and product mix within the current environment is challenging, and we have, and may in the future, incur costs associated with excess inventory, or lose sales from having too few products.
To remain competitive and stimulate consumer and business demand, generally and in compliance with newly proposed or future regulations, we must successfully manage new product introductions and transitions of products and services.
+7 more — sign up free →
REMOVED
Such aggregate market value was computed by reference to the closing price of the common stock as reported on the Nasdaq Global Select Market on June 28, 2024.
The number of outstanding shares of the registrant s common stock, $0.001 par value, was 28,868,940 shares as of February 7, 2025.
Risks Related to our Business, Industry and Operations Optimizing our channel partners' inventory levels and product mix within the current environment is challenging, and we have, and may in the future, incur costs associated with excess inventory, or lose sales from having too few products.
To remain competitive and stimulate consumer and business demand, we must successfully manage new product introductions and transitions of products and services.
Our sales and operations in international markets have exposed us to and may in the future expose us to operational, financial and regulatory risks.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →